Session Details
[2S09e]Cutting-edge medical innovation based on RNA chemical modification
Tue. Nov 4, 2025 4:30 PM - 6:30 PM JST
Tue. Nov 4, 2025 7:30 AM - 9:30 AM UTC
Tue. Nov 4, 2025 7:30 AM - 9:30 AM UTC
Room9(Room 104)
Organizers:Hideshi Ishii(The University of Osaka), Masamitsu Konno(National Institute of Advanced Industrial Science and Technology / Research Institute for Science & Technology, Tokyo University of Science / Graduate School of Nanobioscience, Yokohama City University / Graduate School of Medicine, Osaka University )
[2S09e-01]Understanding the mechanism of cancer malignant transformation and its clinical application using 200-dimensional RNA biology
○Masamitsu Konno1,2,3,4 (1.National Institute of Advanced Industrial Science and Technology, 2.Research Institute for Science & Technology, Tokyo University of Science, 3.Graduate School of Nanobioscience, Yokohama City University, 4.Graduate School of Medicine, Osaka University)
キーテクノロジー:RNA計測
[2S09e-02]Modified nucleoside detoxification pathway safeguards cellular metabolism
○Akiko Ogawa (Graduate School of Pharmaceutical Sciences, Tohoku University)
キーテクノロジー:RNA修飾
[2S09e-03]Targeting RNA Modifications to Overcome Translation-Dependent Cancers
○Atsushi Fujimura1, Yusuke Otani2, Atsushi Tanaka2, Akira Ohtsu2 (1.Dept. Molecular Physiology, Faculty of Medicine, Kagawa University, 2.Beth Israel Deaconess Medical Center, Harvard Medical School)
キーテクノロジー:Epi-transcriptome analysis
[2S09e-04]Single-Molecule Quantum Detection of RNA Modifications for Personalized Medicine
○Takahito Ohshiro, Yuki Komoto, Masateru Taniguchi (The University of Osaka)
キーテクノロジー:nanotechnolgy
[2S09e-05]Programmable in vivo CAR-T therapy via epitranscriptomic modification and tunable lipid nanoparticles
○Sikun Meng1, Tomoaki Hara1, Yoshiko Saito1, Yutaka Miura2, Hideshi Ishii1 (1.Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, 2.Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo)
キーテクノロジー:in vivo CAR-T immunotherapy
[2S09e-06]m6A modified RNA fragments as a candidate of oligonucleotide therapeutics targeting ALS
○Ryoma Yoneda1, Naomi UEDA1, Masataka HIRASAKI2 (1.Div. Biomed. Sci., School of Medicine, Saitama Med. Univ., 2.Dept. of Clin. Cancer Genomics, Int. Med.Center, Saitama Med. Univ.)
キーテクノロジー:RNA pull down assay
[2S09e-07]RNA Methylation in Pancreatic Cancer: From Therapeutic Resistance to Targeted Intervention
○Shotaro Tatekawa1,2, Tomoaki Hara2, Sikun Meng2, Tetsuya Sato3,4, Keisuke Tamari1, Masamitsu Konno5, Yuichiro Doki6, Hidetoshi Eguch6, Kazuhiko Ogawa1, Hideshi Ishiii2 (1.Department of Radiation Oncology, The University of Osaka Graduate School of Medicine, 2.Department of Medical Data Science, The University of Osaka Graduate School of Medicine, 3.Saitama Medical University, 4.H.U. Group Research Institute G.K., 5.National Institute of Advanced Industrial Science and Technology, 6.Department of Gastroenterological Surgery, The University of Osaka Graduate School of Medicine)
キーテクノロジー:RNA modification
[2S09e-08]Epitranscriptomic Profiling of Serum miRNAs as Predictive Biomarkers for Post-SVR Hepatocellular Carcinoma
○Takehisa Watanabe1, Takahito Ohshiro2, Hideshi Isihi3, Yasuhito Tanaka1 (1.Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, 2.The Institute of Science and Industrial Research, Osaka University,, 3.Department of Medical Data Science, Osaka University Graduate School of Medicine)
キーテクノロジー:Nanochannel integrated device
